Clinical Trials
3 trialsNCT06317298 2024-03-19
Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy
Peking University First Hospital
Phase NA Unknown
NCT01107509 2018-04-04
Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers
St. Joseph's Healthcare Hamilton
Phase NA Completed
NCT02208128 2014-08-04
MORE
Heidelberg University
Phase NA Unknown